Head-to-Head Against Pembrolizumab: Innovent Announces First Patient Dosed in the First Pivotal Study of IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Melanoma

SAN FRANCISCO and SUZHOU, China, March 3, 2025 /PRNewswire/ — Innovent Biologics, Inc.…

Dive into sound with Suunto Aqua

SYDNEY, March 3, 2025 /PRNewswire/ — Suunto brings high-quality underwater audio with…

ANICAV to participate in Foodex Japan 2025 with Cooking Demos and Tasting Sessions highlighting Red Gold Tomatoes from Europe

TOKYO, March 3, 2025 /PRNewswire/ — ANICAV, the Italian National Association of…

Breakthrough! Exciting interim Phase II Data of LP-003 in CSU released by Longbio at AAAAI 2025

SAN DIEGO, March 3, 2025 /PRNewswire/ — Longbio Pharma (Suzhou) Co., Ltd.…

HONOR Unveils Groundbreaking AI-Powered Earbuds Open at MWC 2025

BARCELONA, Spain, March 3, 2025 /PRNewswire/ — Global technology brand HONOR today…

HONOR Introduces the Ultra-thin HONOR Pad V9 at MWC 2025

BARCELONA, Spain, March 3, 2025 /PRNewswire/ — HONOR today announced the HONOR…

HONOR Unveils the Stunning HONOR Watch 5 Ultra at MWC 2025

BARCELONA, Spain, March 3, 2025 /PRNewswire/ — Global technology brand HONOR today…

Thailand and European Free Trade Association Sign FTA

Key Takeways On January 23, the Prime Minister attended the signing of…